The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain
Open accessAbstract
In Alzheimer disease brain the activities of protein phosphatase (PP)-2A and PP-1 are decreased and the microtubule-associated protein tau is abnormally hyperphosphorylated at several sites at serine/threonine. Employing rat forebrain slices kept metabolically active in oxygenated artificial CSF as a model system, we investigated the role of PP-2A/PP-1 in the regulation of some of the major abnormally hyperphosphorylated sites of tau and the protein kinases involved. Treatment of the brain slices with 1.0 microM okadaic acid inhibited approximately 65% of PP-2A and produced hyperphosphorylation of tau at Ser 198/199/202, Ser 396/404 and Ser 422. No significant changes in the activities of glycogen synthase kinase-3 (GSK-3) and cyclin dependent protein kinases cdk5 and cdc2 were observed. Calyculin A (0.1 microM) inhibited approximately 50% PP-1, approximately 20% PP-2A, 50% GSK-3 and approximately 30% cdk5 but neither inhibited the activity of cyclin AMP dependent protein kinase A (PKA) nor resulted in the hyperphosphorylation of tau at any of the above sites. Treatment of brain slices with 1 microM okadaic acid plus 0.1 microM calyculin A inhibited approximately 100% of both PP-2A and PP-1, approximately 80% of GSK-3, approximately 50% of cdk5 and approximately 30% of cdc2 but neither inhibited PKA nor resulted in the hyperphosphorylation of tau at any of the above sites. These studies suggest (i) that PP-1 upregulates the phosphorylation of tau at Ser 198/199/202 and Ser 396/404 indirectly by regulating the activities of GSK-3, cdk5 and cdc2 whereas PP-2A regulates the phosphorylation of tau directly by dephosphorylation at the above sites, and (ii) that a decrease in the PP-2A activity leads to abnormal hyperphosphorylation of tau at Ser 198/199/202, Ser 396/404 and Ser 422.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PP2A has been shown to regulate GSK3 b activity by removing phosphorylation at serine 9 and other regulatory residues (Bennecib et al., 2000; Mitra et al., 2012).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Bennecib et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,288
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Bialojan, C., & Takai, A. (1988) · Biochemical Journal · doi:10.1042/bj2560283 · Cited by 1,689
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,373
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Research works printed but not linked: 2
- 10.1016/0197-4580(95)00033-B · DOI
- Ishihara H., 1989, J. Pharmacol. Exp. Ther., 250, 388
Cited by
Sorted by citations
Items 101–184 of 184
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications
Gould, T. D. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.377 · Cited by 40
Hypothermia and Alzheimers Disease Neuropathogenic Pathways
Whittington, R. A., Papon, M.-A., Chouinard-Decorte, F., & Planel, E. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611646 · Cited by 42
Chen, L.-J., Wang, Y., & Tseng, G. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1308 · Cited by 39
Zhen, X., Torres, C. A., Cai, G., & Friedman, E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1356 · Cited by 36
How it all Started: Tau and Protein Phosphatase 2A
Liu, C., & Götz, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130503 · Cited by 38
Koivisto, L., Häkkinen, L., Matsumoto, K., McCulloch, C. A., Yamada, K. M., & Larjava, H. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.026 · Cited by 35
Tau and Alzheimer's disease: Past, present and future
Iqbal, K. (2024) · Cytoskeleton · doi:10.1002/cm.21822 · Cited by 35
Signal Transduction Therapeutics: Relevance for Alzheimer's Disease
Silva, O. A. B. D. C. E., Fardilha, M., Henriques, A. G., Rebelo, S., Vieira, S. I., & Silva, E. F. D. C. E. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:123 · Cited by 34
Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress
Camões, F., Henriques, A. G., Silva, O. A. B. D. C. E., & Silva, E. F. D. C. E. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2003.12.007 · Cited by 34
Glibo, M., Šerman, A., Karin‐Kujundžić, V., Vlatković, I. B., Mišković, B., Vranić, S., & Šerman, L. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5036 · Cited by 37
Jiang, X., Tian, Q., Wang, Y., Zhou, X., Xie, J., Wang, J., & Zhu, L. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07355.x · Cited by 33
Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach
Castro-Álvarez, J. F., Uribe‐Arias, A., MejÃa-Raigosa, D., & Cardona‐Gómez, G. P. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00232 · Cited by 34
Sun, C., Qi, S., Lou, X., Sun, S., Wang, X., Dai, K.-Y., Hu, S., & Liu, N.-B. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200601020-00008 · Cited by 31
Modeling Tauopathy in the Fruit Fly Drosophila melanogaster
Khurana, V. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15403 · Cited by 31
Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
González, A., Singh, S. K., Churruca, M., & Maccioni, R. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084192 · Cited by 30
Tau hyperphosphorylation affects Smad 2/3 translocation
Baig, S., Helmond, Z. V., & Love, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.045 · Cited by 30
Glycogen synthase kinase-3 signaling in cellular and behavioral responses to psychostimulant drugs
Barr, J. L., & Unterwald, E. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118746 · Cited by 29
Zhou, J. H. S., Wang, H., Feng, Y., & Chen, J. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.009 · Cited by 27
Zhang, Y., Li, H.-L., Wang, D.-L., Liu, S.-J., & Wang, J. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0421-2 · Cited by 27
A pool of β‐tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain
Vijayan, S., El-Akkad, E., Grundke, I., & Iqbal, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03201-x · Cited by 27
Castro-Álvarez, J. F., Uribe‐Arias, A., & Cardona‐Gómez, G. P. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23576 · Cited by 26
Ren, Q., Liao, X., Wang, X., Qu, Z.-S., & Wang, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.073 · Cited by 26
Wang, X., Blanchard, J., Tung, Y. C., Grundke, I., & Iqbal, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142403 · Cited by 26
Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures
Lin, R., Jones, N. C., & Kwan, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103676 · Cited by 24
Kukuruzinska, M. A. (2009) · Cell Health and Cytoskeleton · doi:10.2147/chc.s5965 · Cited by 23
Chen, Y. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.007 · Cited by 23
Zhao, Y., Pei, J.-J., Ji, Z., Zhao, Z., Qian, Y.-Y., & Sheng, S. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00012 · Cited by 22
Yu, D., Luo, J., Bu, F., Song, G., Zhang, L.-Q., & Wei, Q. (2006) · Biological Chemistry · doi:10.1515/bc.2006.121 · Cited by 22
BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR
Makani, V. S., Jang, Y.-G., Christopher, K., Judy, W., Eckstein, J. M., Hensley, K., Chiaia, N. L., Kim, D.-S., & Park, J. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149715 · Cited by 21
Pérez‐Gómez, A. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh139 · Cited by 21
Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo.
Liu, S. J., Fang, Z., Yang, Y., Deng, H. M., & Wang, J. Z. (2003) · PubMed · Cited by 20
Xu, G., Deng, Y.-Q., Liu, S.-J., Li, H.-L., & Wang, J. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2005.00050.x · Cited by 19
Budni, J., Molz, S., Dal-Cim, T. A., Martin‐de‐Saavedra, M. D., Egea, J., López, M. G., Tasca, C. I., & Rodrigues, A. L. S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0425-6 · Cited by 18
de Paula, V. D. J. R., Schaeffer, E. L., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.07.006 · Cited by 18
Dual function of protein phosphatase 5 (PPP5C): An emerging therapeutic target for drug discovery
Zhang, H., Zhang, Q., Tu, J., You, Q., & Wang, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115350 · Cited by 16
Ponce-López, T., Hong, E., Abascal-Díaz, M., & Meneses, A. (2017) · Advances in Alzheimer s Disease · doi:10.4236/aad.2017.61002 · Cited by 17
Peng, C., Hong, X., Chen, W., Zhang, H., Tan, L., Wang, X., Ding, Y., & He, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.066 · Cited by 16
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Flynn, C. M., & Yuan, Q. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1159314 · Cited by 15
Migone, F., DeInnocentes, P., Smith, B. F., & Bird, R. C. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20707 · Cited by 14
Effects of 5-Aza on p-Y1472 NR2B related to learning and memory in the mouse hippocampus
Zhang, X., Xie, Y., Xu, W., Liu, X., Jiang, S., Bao, M., Xie, W., Jia, X., Bade, R., Gong, K., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.090 · Cited by 13
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
Fan, X., Xia, L., Zhou, Z., Qiu, Y., Zhao, C., Yin, X., & Qian, W. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.908881 · Cited by 14
Wang, B., Sun, X., Wang, J., Deng, X., Lin, Y., Liu, F., Dong, R., Lin, X., & Bi, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772795 · Cited by 10
Oliveira, J. M., Silva, C. B. D. C. E., Müller, T., Martins, T. S., Cova, M. M., Silva, O. A. B. D. C. E., & Henriques, A. G. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0108 · Cited by 10
Modulation of dendritic spines by protein phosphatase-1
Platholi, J., & Hemmings, H. C. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.10.001 · Cited by 8
Ser/Thr phosphatases: One of the key regulators of insulin signaling
Yadav, Y., & Dey, C. S. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09727-8 · Cited by 9
Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals
Maurage, C., Sergeant, N., Ruchoux, M., Hauw, J., & Delacourte, A. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00007 · Cited by 8
Yadav, Y., Sharma, M., & Dey, C. S. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01071-x · Cited by 7
Kim, H., Takegahara, N., & Choi, Y. (2023) · Cells · doi:10.3390/cells12151967 · Cited by 7
Cardozo, V., Vaamonde, L., Parodi‐Talice, A., Zuluaga, M. J., Agrati, D., Portela, M. M., Lima, A. E., Blasina, F., Dajas, F., & Bedó, G. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105064 · Cited by 7
Benítez‐King, G., Ortíz‐López, L., Morales‐Mulia, S., Jiménez-Rubio, G., Ramírez-Rodríguez, G. B., & Meza, I. (2006) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488906777452776 · Cited by 7
Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
Yu, H. K. Y., Zaveri, S., Sattar, Z., Schaible, M., Gandara, B. P., Uddin, A., McGarvey, L. R., Ohlmeyer, M. H. J., & Geraghty, P. M. (2023) · Medicina · doi:10.3390/medicina59091552 · Cited by 5
Combined phospho‐ and glycoproteome enrichment in nephrocalcinosis tissues of phytate‐fed rats
Tran, T., Park, J., Kim, O., Kim, B., Choi, D., Lee, J., Kim, K. P., Oh, B., & Lee, H. (2013) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6742 · Cited by 4
Krabbe, J. G., Gao, F., Li, J., Ahlskog, J. E., Lingeman, H., Niessen, W. M. A., & Irth, H. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.05.085 · Cited by 4
El-kott, A. F., El-Kenawy, A. E.-M., ElBealy, E. R., Alshehri, A. S., Khalifa, H. S., Bin-Meferij, M. M., Massoud, E. E. S., & Al‐Ramlawy, A. M. (2021) · Biocell · doi:10.32604/biocell.2021.015464 · Cited by 3
Utrera, J., Junyent, F., de Lemos, L., Pallàs, M., Camins, A., Romero, R., & Auladell, C. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22284 · Cited by 3
Protocadherin-7 Regulates Monocyte Migration Through Regulation of Small GTPase RhoA and Rac1
Kim, H., Takegahara, N., & Choi, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020572 · Cited by 2
The Expression and Regulation of GSK-3â, CDK-5 and PP2A in Differentiated Neural Stem Cells of Rats
Qing-xia, Z., Xu, Y., Yan, W., Xue-fei, H., & Xing, Y. (2011) · Cited by 2
Hoyer, S., & Frölich, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_12 · Cited by 2
Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
Kazim, S. F., & Iqbal, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00002-8 · Cited by 2
Tam, J. H. K., & Pasternak, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00004-5 · Cited by 2
Structural and functional studies of proteins in cell signaling and cancer
Dovega, R. (2014) · Figshare · Cited by 2
Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson’s disease
Athanasopoulos, P. S., Memou, A., Ho, F. Y., Soliman, A., Pots, H., Papadopoulou, V., von Zweydorf, F., Sriraman, S., Thouin, A. M., Vandewynckel, L., et al. (2026) · Biochemical Journal · doi:10.1042/bcj20260194 · Cited by 1
Chen, G., & Manji, H. K. (2007) · Medical psychiatry · doi:10.3109/9781420021158.006 · Cited by 1
Effect of Ginkgo biloba Extract EGb 761 on Differential Gene Expression in the Brain
Wolffram, S., & Cermak, R. (2005) · Oxidative stress and disease · doi:10.1201/9781420028096.ch16 · Cited by 1
La melatonina: un coadyuvante potencial en el tratamiento de las demencias
Jiménez-Rubio, G., Ugalde, Ó., Ortíz‐López, L., Ramírez-Rodríguez, G. B., & Benítez‐King, G. (2008) · Redalyc (Universidad Autónoma del Estado de México)
Pseudophosphorylation of tau modulates its function and induces AD-like changes
Sun, Q. (2009) · KU ScholarWorks (The University of Kansas)
Currais, A. J. M., Malik, B. A., Hortobágyi, T., & Soriano, S. (2008) · University of Debrecen Electronic Archive (University of Debrecen)
Medicinal ChemistryApproaches for theTreatment and Prevention of Alzheimer's Disease
Бачурин, С. О. (2003)
Chen, J., Lee, J., Bao, C., Kim, J. T., & Lee, H. J. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.044
Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease
Nirvanashetty, S. (2024) · Swinburne figshare (Swinburne University of Technology) · doi:10.25916/sut.26278636
Garcia, Y. S. A. J. G. N. (2013) · CRC Press eBooks · doi:10.1201/b15421-3
Galik-Olah, Z. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9739
Wang, B., Sun, J., He, T., Deng, Y. X., Lin, N., Liu, H. F., Lin, X., Dong, R., Liu, Q. Y., & Bi, Y.-L. (2021) · Research Square · doi:10.21203/rs.3.rs-138907/v1
Ochoa, C. D., Balczon, R., & Stevens, T. (2013)
Wang, B., Lin, X., Sun, X., Liu, F. H., He, T., Deng, X., Lin, Y., Dong, R., & Bi, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-420209/v1
Obrenovich, M. E., Raina, A. K., Ogawa, O., Atwood, C., Morelli, L., & Smith, M. A. (2007) · Springer eBooks · doi:10.1007/0-387-29390-6_6
Pathogenesis of Alzheimer Disease: Metabolic Factors
(2004) · Springer eBooks · doi:10.1007/0-306-48529-x_15
Soltanian, B., Shasaltaneh, M. D., Riazi, G., & Masoudian, N. (2022) · PubMed Central · doi:10.22074/cellj.2022.7917
Leucine Carboxyl Methyltransferase
Melideo, S. L., Ha, J. Y., & Stock, J. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101594
Leucine Carboxyl Methyltransferase
Melideo, S. L., Ha, J. Y., & Stock, J. B. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101594-1
Yadav, Y., Sharma, M., & Dey, C. S. (2024) · Figshare · doi:10.6084/m9.figshare.26584101
Tau nucléaire : un acteur clé dans le stress neuronal
Sultan, A. (2010) · theses.fr (ABES) · doi:10.70675/98c582c8z1d31z4edazbbfaz92750b338b46
Chojnacki, J. E. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/62wy-9639
Metadata
- Authors
- Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K.
- Affiliations
- New York State Office for People With Developmental Disabilities (US)
- Corresponding author
- Iqbal, Khalid
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2000-11-14
- Volume
- 485
- Issue
- 1
- Pages
- 87-93
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1977560589
- Cited by
- 184
- References
- 54
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 5 · 2014: 10 · 2013: 9 · 2012: 4
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- City University of New York
- Northwestern University
- University of Tokyo
- National Institutes of Health (5r01ag008076-09, 5r01ag005892-16, 1r03ag014875-01)
- National Institute on Aging (AG-05892, AG 08076, AG14875)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- protein phosphatase 2A, protein phosphatase 1, tau hyperphosphorylation, glycogen synthase kinase-3, cyclin-dependent kinase 5, cdc2, okadaic acid, calyculin A, Alzheimer's disease, tau dephosphorylation, kinase regulation, rat brain, tau phosphorylation sites, protein phosphatase inhibition
- MeSH terms
- Animals, Enzyme Inhibitors, Female, Marine Toxins, Oxazoles, Phosphoprotein Phosphatases, Phosphorylation, CDC2 Protein Kinase, Prosencephalon, tau Proteins, Rats, Wistar, Calcium-Calmodulin-Dependent Protein Kinases, Cyclin-Dependent Kinases, Okadaic Acid, Glycogen Synthase Kinases, Glycogen Synthase Kinase 3, Cyclin-Dependent Kinase 5, Rats, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review